SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8513321DFC14325731C88609FC554438567BD338D1513EFA679C799DBDC97CC377DF9046C16729BF3329F958E471DC94>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8513321DFC14325731C88609FC554438567BD338D1513EFA679C799DBDC97CC377DF9046C16729BF3329F958E471DC94
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8513321DFC14325731C88609FC554438567BD338D1513EFA679C799DBDC97CC377DF9046C16729BF3329F958E471DC94
http://www.w3.org/2000/01/rdf-schema#comment
"Soluble VSIG4 levels are associated with the progression and recurrence of ovarian cancer indicating that soluble VSIG4 may be used as a potential biomarker for predicting tumor prognosis."
xsd:string
http://purl.uniprot.org/uniprot/#_1F23E682832D3AE628EF4FA5E091C04BF888679327EE1B9D299192823C141524311CCA5C5064EDF7F4BD8A1F37EE0CB5
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8513321DFC14325731C88609FC554438567BD338D1513EFA679C799DBDC97CC377DF9046C16729BF3329F958E471DC94
http://purl.uniprot.org/uniprot/Q9Y279
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8513321DFC14325731C88609FC554438567BD338D1513EFA679C799DBDC97CC377DF9046C16729BF3329F958E471DC94
http://purl.uniprot.org/uniprot/#_Q9Y279-mappedCitation-28498255
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8513321DFC14325731C88609FC554438567BD338D1513EFA679C799DBDC97CC377DF9046C16729BF3329F958E471DC94